- ticket title
- Libya: COVID-19 Flash Update No. 2 (6 April 2020)
- UN Calls For Cease-Fire In Libya On Anniversary Of Armed Conflict
- Trump Pushes Unproven COVID Treatment
- Displacement Tracking Matrix (DTM) Libya IDP and Returnee Report: Mobility Tracking Round 29 | January – February 2020
- Libya – IDP and Returnee Key Findings Report 29 (Jan-Feb 2020)
Newly Implemented Systems Help Increase Patient Safety and Satisfaction
MOUNTAIN VIEW, California, May 2, 2017 /PRNewswire/ — Omnicell, Inc. (NASDAQ: OMCL) today announced that the Dubai Health Authority (DHA) has implemented its robotic dispensing systems in both Rashid and Dubai Hospitals to reduce the public’s waiting period to receive medicines and increase patient satisfaction. The mission of the DHA—which includes hospitals, specialty centers, and DHA primary health centers—is to transform Dubai into a leading healthcare destination by fostering innovative and integrated care models and by enhancing community engagement.
The DHA chose to implement Omnicell’s Robomat robotic dispensing system—consisting of the Medimat storage and dispensing unit and the Speedbox filling system—in order to achieve maximum automation with minimal manual input and provide quicker, safer, and more efficient dispensing. The Omnicell technology will help speed up the process to prescribe medicine to patients, and increase accuracy in measuring, leading to greater patient satisfaction.
The robotic dispensing systems will not only reduce customer waiting time but enable the pharmacist to spend more time with patients to give detailed instructions and information regarding their medications.
“Implementing the Omnicell robotic dispensing solution is an important step in significantly decreasing the patient waiting time and increasing the efficiency of the outpatient pharmacy to provide our patients with an excellent healthcare service. This is in line with our mission to develop an integrated and sustainable healthcare system that helps ensure the delivery of comprehensive and excellent services,” said Dr. Ali Al Sayed Hussain, director, Pharmacy Department with the Dubai Health Authority. “We look forward to further cooperation with Omnicell and introducing automation solutions in the inpatient department to achieve the highest international standards in the health of individuals and the community.”
“We are pleased that the Dubai Health Authority chose to implement Omnicell’s robotic dispensing systems to improve safety and patient satisfaction within their network,” said Baha El Mahgoub, general manager, Central & Eastern Europe at Omnicell. “We look forward to expanding our partnership with additional technologies to help them provide the highest standards of care.”
About Dubai Health Authority
The Dubai Health Authority (DHA) was created, in June 2007, by Law 13 issued by His Highness Sheikh Mohammed bin Rashid Al Maktoum, Vice President and Prime Minister of the UAE, Ruler of Dubai, with an expanded vision to include strategic oversight for the complete health sector in Dubai and enhance private sector engagement. His Highness Sheikh Hamdan Bin Rashid Al Maktoum, Deputy Ruler of Dubai and UAE Minister of Finance is the President of the Dubai Health Authority and His Excellency Humaid Mohammed Obaid Al Qatami is the chairman of the board of the Dubai Health Authority.
The DHA’s aim in Dubai is to provide an accessible, effective and integrated healthcare system, protect public health and improve the quality of life within the Emirate. This is a direct translation of the objectives of the Dubai Strategic Plan 2015 launched by His Highness Sheikh Mohammed bin Rashid Al Maktoum. Keeping the strategic plan in mind, the DHA’s mission is to ensure access to health services, maintain and improve the quality of these services, improve the health status of nationals, residents and visitors and oversee a dynamic, efficient and innovative health sector.
In addition to overseeing the health sector for the Emirate of Dubai, the DHA also focuses on providing services through DHA healthcare facilities including hospitals (Latifa, Dubai, Rashid and Hatta), specialty centres (e.g. the Dubai Diabetes Center) and DHA primary health centres spread throughout the Emirate of Dubai.
The main pillars of service delivery at DHA health facilities are quality, efficiency, patients and staff. It is our aim to maintain and improve the quality and efficiency of DHA health services. An important aspect of the service delivery strategy is to focus on patients, their needs and satisfaction as well as attract, retain, nurture and support outstanding staff.
Prior to the establishment of the DHA, the Department of Health and Medical Services (DOHMS), which was established in 1973, was the functioning authority that almost exclusively focused on health service delivery.
Since 1992, Omnicell (NASDAQ: OMCL) has been inspired to create safer and more efficient ways to manage medications and supplies across all care settings. As a leader in medication and supply dispensing automation, central pharmacy automation, IV robotics, analytics software, and medication adherence and packaging systems, Omnicell is focused on improving care across the entire healthcare continuum—from the acute care hospital setting, to post-acute skilled nursing and long-term care facilities, to the patient’s home.
Over 4,000 customers worldwide use Omnicell® automation and analytics solutions to increase operational efficiency, reduce medication errors, deliver actionable intelligence and improve patient safety.
Omnicell’s innovative medication adherence solutions, used by over 32,000 institutional and retail pharmacies in North America and the United Kingdom, are designed to improve patient adherence to prescriptions, helping to reduce costly hospital readmissions.
Recent Omnicell acquisitions, including Ateb, add distinct capabilities, particularly in central pharmacy, IV robotics, and pharmacy software, creating the broadest medication management product portfolio in the industry.
For more information about Omnicell, Inc. please visit www.omnicell.com.
- All Omnicell news releases (financial, acquisitions, products, technology etc.) are issued exclusively by PR Newswire and are immediately thereafter posted on the company’s external website, omnicell.com.
- Omnicell and the Omnicell logo design are registered trademarks of Omnicell, Inc.
- All other brand or product names may be trademarks or registered trademarks of their respective companies.